Glass flakes: Pre-testing stops a big problem before it even starts
Download the whitepaper to explore how pre-testing glass flakes can prevent a major problem before it starts!
Glass delamination has emerged as a significant problem for the pharmaceutical industry, causing the recalls of numerous injectable drug products over the past several years. No single factor causes glass delamination in a pharmaceutical setting, and it can be a complex problem to address because it typically doesn’t show up until the product has been stored in the container for several months. Because of the situation's complexity and the delay before the problem appears, there is no simple fix once delamination has been observed. Nevertheless, there are concrete steps that pharma companies can take to minimize the risks of glass flakes. The key is to conduct container/drug product compatibility testing before commercialization.
Read the whitepaper now to learn how pharmaceutical companies can use accelerated testing to select the proper containers for their drug products and avoid costly mistakes!
This article was initially published in Contract Pharma in June 2013.
Glass delamination has emerged as a significant problem for the pharmaceutical industry, causing the recalls of numerous injectable drug products over the past several years. No single factor causes glass delamination in a pharmaceutical setting, and it can be a complex problem to address because it typically doesn’t show up until the product has been stored in the container for several months. Because of the situation's complexity and the delay before the problem appears, there is no simple fix once delamination has been observed. Nevertheless, there are concrete steps that pharma companies can take to minimize the risks of glass flakes. The key is to conduct container/drug product compatibility testing before commercialization.
Read the whitepaper now to learn how pharmaceutical companies can use accelerated testing to select the proper containers for their drug products and avoid costly mistakes!
This article was initially published in Contract Pharma in June 2013.
